Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

For every 1,000 employees, about $580,000 is spent each year in excess healthcare costs and lost work time from five ...

The FDA review – which is due to be completed by 28th September – revolves around the results of the HERCULES trial which ...

Walk MS is two weeks away, and more than 1,500 people in the area are hard at work fundraising and building their teams.

Learn about multiple sclerosis (MS), a condition affecting younger individuals, its symptoms, causes, diagnosis, treatment, ...

In a 20-question test of neurologists (6 with MS specialty) and AI platforms, the bots did better than all but the ...

—Researchers at the University of Houston recently found that high-efficacy disease-modifying agents decreased the risk of relapse in male patients with multiple sclerosis versus moderate ...

Multiple sclerosis, or MS affects a million Americans a year. It can lead to a range of symptoms. It’s a chronic illness that ...

Dr Pavan Bhargava shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights into how new ...

Cladribine is part of a wider trend in the NHS toward embracing time-saving innovations. Similar treatments, such as the ...

March is regonized as multiple sclerosis awareness month. One woman is shining a light on MS and sharing a message of hope ...

Dr Shiv Saidha of Johns Hopkins University and his patient discuss strategies to convey a new diagnosis of multiple sclerosis and to foster shared decision-making for optimal disease management.